Evidence map›Paper›PMID 29897324›Full record

ArticleBMC bioinformatics2018

In silico prediction of potential chemical reactions mediated by human enzymes.

Myeong-Sang Yu, Hyang-Mi Lee, Aaron Park, Chungoo Park, Hyithaek Ceong, Ki-Hyeong Rhee, Dokyun Na

Abstract read
In one paragraph

Article in BMC bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Myeong-Sang YuSchool of Integrative Engineering, Chung-Ang University, Seoul, Republic of Korea.
Hyang-Mi LeeSchool of Integrative Engineering, Chung-Ang University, Seoul, Republic of Korea.
Aaron ParkSchool of Biological Sciences, Chonnam National University, Gwangju, Republic of Korea.
Chungoo ParkSchool of Biological Sciences, Chonnam National University, Gwangju, Republic of Korea.
Hyithaek CeongDepartment of Multimedia, Chonnam National University, Yeosu, Republic of Korea.
Ki-Hyeong RheeCollege of Industrial Sciences, Kongju National University, Yesan, Republic of Korea.
Dokyun NaSchool of Integrative Engineering, Chung-Ang University, Seoul, Republic of Korea. blisszen@cau.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdministered drugs are often converted into an ineffective or activated form by enzymes in our body. Conventional in silico prediction approaches focused on therapeutically important enzymes such as CYP450. However, there are more than thousands of different cellular enzymes that potentially convert administered drug into other forms.

resultWe developed an in silico model to predict which of human enzymes including metabolic enzymes as well as CYP450 family can catalyze a given chemical compound. The prediction is based on the chemical and physical similarity between known enzyme substrates and a query chemical compound. Our in silico model was developed using multiple linear regression and the model showed high performance (AUC = 0.896) despite of the large number of enzymes. When evaluated on a test dataset, it also showed significantly high performance (AUC = 0.746). Interestingly, evaluation with literature data showed that our model can be used to predict not only enzymatic reactions but also drug conversion and enzyme inhibition.

conclusionOur model was able to predict enzymatic reactions of a query molecule with a high accuracy. This may foster to discover new metabolic routes and to accelerate the computational development of drug candidates by enabling the prediction of the potential conversion of administered drugs into active or inactive forms.

Indexed as

Computer SimulationAlgorithmsArea Under CurveDatabases, ProteinEnzymesHumansModels, BiologicalEnzymesDrug discoveryEnzyme reaction predictionIn silico modelMachine learning

Identifiers

PMID29897324
PMCPMC5998764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.